Given the limitations of treating its acute clinical manifestations, further studies are warranted to understand and discover new approaches for earlier diagnosis and treatment of XIAP deficiency to prevent the cascade of clinical manifestations that lead to mortality in this population. The gene discussed is XIAP; the disease is hyperinsulinemic hypoglycemia, familial, 4.